Active substances
Amlodipine + Perindopril
- SFDA 26
- US FDA 1
- Health Canada 9
SFDA Saudi Arabia — SFDA human drug list
| Trade name | Strength | Form · route | Pack | Public price | Type | Company | Status |
|---|---|---|---|---|---|---|---|
| COVERAM 10MG-10MG TABLETS | 10,10 mg,mg | Tablet · Oral use | 30 Bottle | SAR 117.20 | Generic · Prescription | SERVIER | Valid |
| COVERAM 10MG-5MG TABLETS | 5,10 mg,mg | Tablet · Oral use | 30 Bottle | SAR 102.70 | Generic · Prescription | SERVIER | Valid |
| COVERAM 5MG-10MG TABLETS | 10,5 mg,mg | Tablet · Oral use | 30 Bottle | SAR 82.90 | Generic · Prescription | SERVIER | Valid |
| COVERAM 5MG-5MG TABLETS | 5,5 mg,mg | Tablet · Oral use | 30 Bottle | SAR 68.45 | Generic · Prescription | SERVIER | Valid |
| PROVINDA PLUS | 10,10 mg,mg | Tablet · Oral use | 30 Blister | SAR 85.90 | Generic · Prescription | SPIMACO | Valid |
| PROVINDA PLUS | 10,5 mg,mg | Tablet · Oral use | 30 Blister | SAR 75.35 | Generic · Prescription | SPIMACO | Valid |
| PROVINDA PLUS | 5,10 mg,mg | Tablet · Oral use | 30 Blister | SAR 60.70 | Generic · Prescription | SPIMACO | Valid |
| PROVINDA PLUS | 5,5 mg,mg | Tablet · Oral use | 30 Blister | SAR 50.15 | Generic · Prescription | SPIMACO | Valid |
| Perinam | 3.5,2.5 mg,mg | Tablet · Oral use | 30 Blister | SAR 40.25 | Generic · Prescription | APOTEX | Valid |
| Perinam | 7,5 mg,mg | Tablet · Oral use | 30 Blister | SAR 66.40 | Generic · Prescription | APOTEX | Valid |
| Perinam | 14,10 mg,mg | Tablet · Oral use | 30 Blister | SAR 88.40 | Generic · Prescription | APOTEX | Valid |
| Pratima Duo | 5,10 mg,mg | Tablet · Oral use | 30 Blister | SAR 60.70 | Generic · Prescription | Jazeera Pharmaceutical Industries (JPI) | Valid |
| Pratima Duo | 10,10 mg,mg | Tablet · Oral use | 30 Blister | SAR 85.90 | Generic · Prescription | Jazeera Pharmaceutical Industries (JPI) | Valid |
| Pratima Duo | 10,5 mg,mg | Tablet · Oral use | 30 Blister | SAR 75.35 | Generic · Prescription | Jazeera Pharmaceutical Industries (JPI) | Valid |
| Pratima Duo | 5,5 mg,mg | Tablet · Oral use | 30 Blister | SAR 50.15 | Generic · Prescription | Jazeera Pharmaceutical Industries (JPI) | Valid |
| Prestoprix Plus | 5,5 mg,mg | Tablet · Oral use | 30 Bottle | SAR 50.15 | Generic · Prescription | Med City Pharma | Valid |
| Prestoprix Plus | 5,10 mg,mg | Tablet · Oral use | 30 Bottle | SAR 75.35 | Generic · Prescription | Med City Pharma | Valid |
| Prestoprix Plus | 10,10 mg,mg | Tablet · Oral use | 30 Bottle | SAR 85.90 | Generic · Prescription | Med City Pharma | Valid |
| TENORYL PLUS 10 mg/10 mg TABLET | 10,10 mg,mg | Tablet · Oral use | 30 Bottle | SAR 95.20 | Generic · Prescription | Tabuk Pharmaceutical Manufacturing Company | Valid |
| TENORYL PLUS 10 mg/5 mg TABLET | 5,10 mg,mg | Tablet · Oral use | 30 Bottle | SAR 83.45 | Generic · Prescription | Tabuk Pharmaceutical Manufacturing Company | Valid |
| TENORYL PLUS 5 mg/10 mg TABLET | 10,5 mg,mg | Tablet · Oral use | 30 Bottle | SAR 67.35 | Generic · Prescription | Tabuk Pharmaceutical Manufacturing Company | Valid |
| TENORYL PLUS 5 mg/5 mg TABLET | 5,5 mg,mg | Tablet · Oral use | 30 Bottle | SAR 55.60 | Generic · Prescription | Tabuk Pharmaceutical Manufacturing Company | Valid |
| VIDONORM 10MG/4MG TABLET | 10,4 mg,mg | Tablet · Oral use | 30 Blister | SAR 79.30 | NCE · Prescription | AJA PHARMACEUTICAL INDUSTRIES | Valid |
| VIDONORM 10MG/8MG TABLET | 10,8 mg,mg | Tablet · Oral use | 30 Blister | SAR 90.40 | NCE · Prescription | AJA PHARMACEUTICAL INDUSTRIES | Valid |
| VIDONORM 5MG/4MG TABLET | 5,4 mg,mg | Tablet · Oral use | 30 Blister | SAR 52.80 | NCE · Prescription | AJA PHARMACEUTICAL INDUSTRIES | Valid |
1 more — full table
Indications — CHI Daman Drug Formulary
HYPERTENSION
US FDA United States — FDA approvals (Drugs@FDA)
| Product | Strength | Form · route | Applicant | Status | First approved |
|---|---|---|---|---|---|
| PRESTALIA | EQ 2.5MG BASE;3.5MG; EQ 5MG BASE;7MG; EQ 10MG BASE;14MG | tablet · oral | ADHERA | Discontinued | 21 Jan 2015 |
Canada Canada — marketed products (Health Canada)
| Brand | DIN | Strength | Form · route | Company |
|---|---|---|---|---|
| APO-PERINDOPRIL/AMLODIPINE | 02468565 | 2.5 MG; 3.5 MG | TABLET · ORAL | APOTEX INC |
| APO-PERINDOPRIL/AMLODIPINE | 02468573 | 5 MG; 7 MG | TABLET · ORAL | APOTEX INC |
| APO-PERINDOPRIL/AMLODIPINE | 02468581 | 14 MG; 10 MG | TABLET · ORAL | APOTEX INC |
| PMS-PERINDOPRIL-AMLODIPINE | 02541696 | 2.5 MG; 3.5 MG | TABLET · ORAL | PHARMASCIENCE INC |
| PMS-PERINDOPRIL-AMLODIPINE | 02541718 | 5 MG; 7 MG | TABLET · ORAL | PHARMASCIENCE INC |
| PMS-PERINDOPRIL-AMLODIPINE | 02541726 | 10 MG; 14 MG | TABLET · ORAL | PHARMASCIENCE INC |
| VIACORAM | 02451530 | 3.5 MG; 2.5 MG | TABLET · ORAL | SERVIER CANADA INC |
| VIACORAM | 02451549 | 7 MG; 5 MG | TABLET · ORAL | SERVIER CANADA INC |
| VIACORAM | 02451557 | 10 MG; 14 MG | TABLET · ORAL | SERVIER CANADA INC |
Components
Values as published by each source: SFDA human drug list (4-2026, as published by the Council of Health Insurance; indications from the CHI Daman Drug Formulary), Drugs@FDA, EMA medicines data, Health Canada Drug Product Database (Open Government Licence – Canada), CMS NADAC, NHS Drug Tariff Part VIIIA (NHSBSA Copyright, Open Government Licence v3.0), WHO Model List of Essential Medicines (CC BY 3.0 IGO; regrouped by active substance, not created by WHO), EMA PRAC, US FDA safety-related labeling changes and MHRA Drug Safety Update (Open Government Licence v3.0). Sources and reuse. Not a substitute for the official registers or the product information.